|
|
Article: Pfizer To Acquire CSL Animal Health Business; Acquisition Strengthens Pfizer Animal Health in Australia with Innovative Livestock and Companion Animal Vaccines, A Robust R & D Pipeline, and Unique Manufacturing Capabilities.
- Article from:
- PR Newswire
- Article date:
- December 15, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, Dec. 15 /PRNewswire/ -- Pfizer Animal Health has agreed to acquire CSL Animal Health, a division of CSL Limited (Melbourne, Australia), for $126.2 million in cash, Pfizer announced today. [Please note that all financials are in U.S. dollars.]
The acquisition will enhance Pfizer Animal Health's presence in the Australian marketplace with CSL's well-received line of livestock and companion animal vaccines, its highly professional sales force, and its advanced manufacturing facilities in Australia and New Zealand.
CSL Animal Health has also built a strong, productive research initiative in Australia. With the largest annual investment in animal ...